Status:
RECRUITING
A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females
Lead Sponsor:
Sang-Won Um
Conditions:
Health Risk Behaviors
Eligibility:
FEMALE
45-74 years
Phase:
NA
Brief Summary
This is a single-arm prospective pilot study in a single institution. The target accrual is 200 participants of Korean, female sex, never smoker status, and family history of lung cancer. The study wi...
Detailed Description
Interested individuals will contact a research coordinator who will help to assess for study eligibility. Individuals who are eligible and able to sign informed consent will then proceed to have a LDC...
Eligibility Criteria
Inclusion
- Age 45-74 years old
- Korean female
- Never smoker defined as a lifetime exposure of less than 100 cigarettes
- Family history of lung cancer at first degree relatives (parents, siblings, or children)
Exclusion
- Prior history of lung cancer.
- Diagnosis of any cancer within the past five years
- Participation in a cancer prevention trial.
- Present symptoms suggestive of current lung cancer, including: unexplained weight loss of over 5 kilograms within the last 12 months or unexplained hemoptysis.
- Medical or psychiatric condition precluding informed medical consent.
- History of LDCT screening, chest CT, PET or PET/CT scan within 10 years
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2034
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06181929
Start Date
June 1 2024
End Date
May 31 2034
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, Seoul, South Korea, 06351